Calamp Corp. Stock
Calamp Corp. Stock
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the Calamp Corp. stock is not clear.
With a target price of 6 € there is potential for a 4551.16% increase which would mean more than doubling the current price of 0.13 € for Calamp Corp..
Pros and Cons of Calamp Corp. in the next few years
Pros
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Calamp Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Calamp Corp. | - | - | - | - | - | - | - |
| Spok Holdings Inc. | 0.510% | 3.125% | 8.791% | -36.129% | -9.836% | -23.256% | 50.000% |
| Apt Satellite Hldgs | 0.000% | 0.000% | 0.000% | -8.654% | -24.000% | -25.197% | -19.492% |
| SoftBank Group | 0.200% | 2.832% | -12.749% | -63.472% | 22.259% | -30.808% | -43.024% |
Comments
CAMP4 Therapeutics (CAMP) was upgraded by JPMorgan Chase & Co. from "neutral" to "overweight". They now have a $9.00 price target on the stock, up from $5.00.
Show more
Ratings data for CAMP provided by MarketBeat
CAMP4 Therapeutics (CAMP) was given a new $6.50 price target by Chardan Capital. They now have a "buy" rating on the stock.
Show more
Ratings data for CAMP provided by MarketBeat
CalAmp Corp. (NASDAQ: CAMP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for CAMP provided by MarketBeat
